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DRS SURYA M NAULI, KIMBERLY F ATKINSON & SARMED H KATHEM

The cell’s antenna
Drs Surya M Nauli, Kimberly F Atkinson and Sarmed H Kathem describe their innovative research
in primary cilia and the many international collaborations that have enabled their success

Could you begin by introducing the function
of primary cilia within the body?
SMN: The ability of primary cilia to sense fluid
flow is probably their best studied function.
This enables ciliated cells to sense urine flow
in the kidney, blood flow in the vasculature,
hepatic bile in the liver, digestive fluid in the
pancreas, lacunocanalicular fluid in bone or
cartilage, and more.
Collaborating with Dr Wissam AbouAlaiwi at
the University of Toledo, USA, we found that
primary cilia can regulate cell division and
DNA content, and help the cell to locate itself
within the microenvironment – a process also
known as planar cell polarity. Most recently,
our laboratory has also found a chemicalspecific sensory function of primary cilia in
both vascular endothelia and renal epithelia.
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Aside from the
mechanosensory,
chemosensory
and regulatory cell
division functions of
primary cilia, other
laboratories have also
discovered the roles
of primary cilia in
gravitational sensing,
regulating cell
volume, identifying left-right body formation
during embryogenesis, directing cell migration,
and many others.
Why is it important to gain a solid
understanding of the molecular and
biophysical properties of mechanosensory
and chemosensory primary cilia?
KFA: The importance of primary cilia has only
just begun to be understood. When a cell loses
sensory input from its antenna-like cilium, it
cannot respond to environmental cues and
changes. The mechanosensation of primary
cilia occurs principally in response to fluid shear
stress, while chemosensation refers to the cell’s
ability to sense chemical cues such as ligands in
the blood or neurotransmitters in the synapse.
Dysfunctional cilia are known to be the cause of
a group of diseases termed ciliopathies, which

include polycystic kidney disease (PKD), BardetBiedl syndrome, and primary ciliary dyskinaesia.
These diseases are caused by mutated proteins
in the primary cilium or centrosome. The
association between cilia and centrioles has
opened the possibility for cilia having a role in
cell division and potentially being a good target
in cancer therapy.
Can you describe the translational work you
are undertaking? How are you developing
ciliotherapies to help patients?
SHK: Our research focused on primary cilia
has two goals. The first is to explore the
molecular components of cilia-regulated
signalling pathways. Understanding these would
allow scientists to intervene in the molecular
mechanisms in the hope of correcting abnormal
molecular pathways of the cell. The second goal
is to utilise the knowledge gained to directly
target primary cilia. We achieve this by screening
thousands of small molecules and asking if any
of these compounds would affect primary cilia
function or structure. Then, we examine whether
and how any alteration would affect ciliaregulated signalling pathways in disease.
How did you come to work in this field? To
what extent has collaboration shaped the
research you have conducted?
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Bending with the ﬂow
Researchers at Chapman University, USA, have demonstrated the
importance of the mechanosensory ability of primary cilia – microscopic
hairs on the surface of cells – and led the way in developing novel
treatments for ciliopathic diseases
POLYCYSTIC KIDNEY DISEASE (PKD) is the
most common life-threatening genetic disease
worldwide – affecting about 12.5 million people.
Patients with the condition have multiple fluidfilled cysts in their kidneys that lead to a massive
enlargement of the organ and gradual worsening
of its function, as well as complete failure in many
cases. The lack of available treatment means
patients may eventually require regular dialysis or
a kidney transplant.

SMN: We came to learn about the primary
cilia while completing our National Institutes
of Health (NIH) fellowships with Dr Jing
Zhou at Harvard Medical School in the US,
working on an exciting project related to
PKD. Dr Zhou then introduced me to Dr Ken
Spring, who was an outstanding scientist
from NIH. He was the first to directly
activate mechanical function of cilia using a
micropipette. Dr Spring visited Boston many
times to instruct me in using microscopy to
study this mechanosensory function further.
We were also lucky enough to be guided by
Drs Don Ingber and Joe Bonventre, experts
in cell mechanics and renal physiology. Our
laboratory is currently working on the roles
of primary cilia in the cardiovascular system.
We have thus collaborated with our mentor
and colleague, Dr William Pearce, who is a
renowned cardiovascular physiologist. Having
such wonderful mentors provided us with
excellent experiences and enabled us to attain
a successful research career in cilia biology.
Have any results surprised you thus far?
SMN: Our group has provided a potential new
cellular mechanism for fenoldopam. It was
previously known that fenoldopam-induced
hypotension was achieved by increasing kidney
filtration, but the mechanism by which this
occurred was not understood. Our surprising
data show that the fenoldopam receptor is
exclusively located in the cilia. Activating this
receptor increases cilia length, improving their
function, which in turn induces vasodilation and
increases the kidney (glomerular) filtration rate.

Known as a ciliopathy, PKD is caused by
dysfunction of the primary cilia on the renal
epithelial cells lining the ducts within the kidney.
Primary cilia are microscopic hair-like structures
found on the surface of most mammalian
cells; however, until the 1990s they were not
considered important for cell function. Unlike
the motile cilia that cover certain types of cell
and move in a coordinated manner, only one
non-motile primary cilium is present on each
cell, increasing its surface area for important
roles in sensing a variety of chemical and
mechanical signals.
Primary cilia are mechanosensitive; they
bend in response to fluid-shear stress and
provide information about the external fluid
environment to the cell. Dr Surya M Nauli from
Chapman University, USA, has spent many
years investigating the roles of primary cilia
in PKD and other diseases. In collaboration
with his colleagues, Drs Sarmed H Kathem
and Kimberly F Atkinson, his team is focusing
on how interrupting a cell’s ability to detect
fluid flow leads to disease. “Fluid flow-induced
intracellular signalling regulates various cellular
functions like planar cell polarity, cell division
and differentiation,” Kathem elucidates. “As
PKD patients have dysfunctional fluid flow
mechanosensation, this signalling is also
impaired and, consequently, disorientated renal
cell divisions lead to the formation of cysts – the
prominent feature of PKD.” It is therefore vital
to obtain a better understanding of primary
cilial function in the body, with the ultimate aim
of developing new ways of treating ciliopathies.

CILIAL FUNCTION
PKD is typically caused by a mutation in one of two
genes, PKD1 or PKD2, which encode polycystin 1
(PC1) and PC2 respectively. Both of these proteins
are found on the surface of the cell, localised on
the primary cilium. PC1 has a long structure that
reaches out into the cell’s environment, while PC2
is a calcium-permeable cation channel. The two
form a polycystin complex on the surface of the
primary cilium, which, when activated, can signal
inside the cell.

The team was able to uncover the link between
these proteins and PKD. “Among other ciliary
proteins, Nauli’s research showed that PC1 and
PC2 function as mechanosensory proteins,”
Kathem reveals. “Owing to the unique ciliary
localisation of these proteins, when primary cilia
are bent by the fluid flow, these ciliary proteins
undergo a structural conformation change and
evoke intracellular signals that regulate many
cellular functions.” Nauli’s early work showed
that blocking the function of either PC1 or PC2
was enough to stop kidney epithelial cells from
perceiving the mechanical cues of fluid flow, which
could lead to the regulation of tissue growth and
result in the development of cysts.
Nauli and his colleagues succeeded in defining
the roles that PC1 and PC2 play in primary
cilia mechanosensation. The long extracellular
domain of PC1 extends out into the cell’s
microenvironment and acts as a lever to amplify
stresses at the cell surface, transmitting the
signal to its tightly-associated PC2 channel.
The channel then opens to allow calcium ions
to enter the cell in a flow-induced manner,
enabling the cell to understand the fluid
dynamics of its external environment and
inducing gene expression to regulate growth.
This knowledge was very important for
deepening the researchers’ understanding of
PKD and providing potential targets for future
therapeutic development. “The search for
therapy to treat cilia-associated diseases is, no
doubt, a very complex process,” Nauli explains.
“It will take years or even decades to accomplish
and validate its safety and effectiveness toward
our patients, but we think that we are on the
right path to tackle the challenges.”

PKD, HYPERTENSION AND ANEURYSM
In addition to cyst formation in their kidneys,
patients with PKD often develop high blood
pressure, which manifests around a decade
earlier than in non-PKD patients, as well as other
cardiovascular conditions such as aneurysm.
Interestingly, this is unlikely to be due to the
failing kidney. “PKD patients have hypertension
that emerges early in life, even before renal
function deterioration, which supports the
hypothesis that hypertension in PKD is not
solely the result of a cystic kidney, but rather
stems from inherited endothelial dysfunction,”
Kathem explains. The endothelial cells lining
the blood vessels are known to be able to sense
fluid shear stress. The mechanostimulation of the
cells causes an influx of calcium to initiate the
biosynthesis and release of nitric oxide, which
controls vascular contraction and therefore
regulates blood pressure. The same influx of
WWW.INTERNATIONALINNOVATION.COM 95
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calcium also initiates a complex signalling
cascade to regulate survivin expression and
aneurysm formation.
Nauli and his colleagues used mice lacking PC1,
PC2 or primary cilia to show that primary cilia
are responsible for the initial mechanosensation
of the endothelial cells, using the same PC1-PC2
signalling complex seen in the kidney epithelial
cells. Cells from PKD patients confirmed that
this protein is missing from cilia in their vascular
endothelium – which are therefore unable to
transmit information about increased blood flow –
do not release nitric oxide to stimulate vasodilation
and do not properly maintain blood vessel
architecture. This important discovery explains the
hypertension and aneurysm of PKD patients, and
provides further evidence to show that primary
cilia are mechanosensory microcompartments
important for a range of biological activities. “The
different cell types in the kidney and vasculature
perform different functions, and having abnormal
cilia will have different physiological effects,”
points out Atkinson. “The underlying problem is
the inability of these cells to respond to mechanical
stimulation of fluid flow, thereby affecting renal
morphology, vascular architecture, vascular tone
and blood pressure.”

CHEMOSENSATORY TREATMENT
The length of primary cilia is very important for
their ability to function, which is why they are
highly regulated. In the kidneys, cilia are longer
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SURYA M NAULI received his PhD in
Pharmacology from Loma Linda Medical
School, USA. Specific areas currently under
investigation in his laboratory include
molecular, cellular and biophysical studies
of primary cilia; chemical screening for
pharmacological candidates in vitro; and
development of a more efficient in vivo system
to further characterise the cilia-targeting
therapy in vascular and kidney diseases. Surya’s
research and clinical teams are currently
completing a clinical study strategised for a
targeted therapy in hypertensive patients.
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The group’s research has highlighted the
importance of primary cilial function by providing
a deeper understanding of the ciliopathies that
can lead to disease. Nauli and his team are working
on the basic biology of these structures and the
translation of this knowledge into therapeutics
for the future. “Understanding the molecular and
biophysical basis of cilia function is key to the
development of drugs that target the primary cilia
to treat disease,” Atkinson concludes.
ENDOTHELIAL CILIA
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KIMBERLY F ATKINSON earned her PhD in
Molecular Medicine and Translational Science
from Wake Forest School of Medicine,
USA. She is currently working on the role
of primary cilia in human disease. Potential
avenues of research include the involvement
of primary cilia in ciliopathies such as PKD and
targeting the centrosome and primary cilia in
cancer therapy.
SARMED H KATHEM completed his PhD in
Pharmacology in 2012 with a thesis focusing on
the roles of primary cilia. He was immediately
appointed as a tenured faculty member in the
College of Pharmacy, University of Baghdad,
Iraq. Kathem’s research includes in vitro
and in vivo models and clinical studies. His
clinical expertise includes PKD, hypertension
and ciliotherapy.

CILIA IN
ENDOTHELIAL
CELLS

in wider tubules than in narrower ones. Nauli
discovered the molecular interactions that
regulate ciliary length by rearranging the cell’s
structural elements. He and Kathem began to
screen a range of compounds that might alter
cilial length in order to improve their function.
One promising candidate was fenoldopam, a
drug currently used to treat hypertension, which
stimulated the ciliary chemosensory pathway.
When Nauli and his team tested the drug on a
PKD mouse model, both the length of cilia in
the vascular endothelium and the level of nitric
oxide in the blood increased. Clinical trials in
PKD patients showed that dopamine agonist
treatment led to a reduction in blood pressure,
a groundbreaking result that provided the first
example of a ciliotherapy capable of restoring
primary cilia function in ciliopathic patients.
“Our studies further show that ciliotherapy is a
promising way to treat cilia-associated diseases,
and we are still working on a more efficient agent
that could restore cilia function and thus relieve
hypertension,” Kathem elaborates.

